Ymmunobio Company
Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments. It makes extensive progress in developing antibodies that have an influence on the immune system by reinstating its immune response to cancers or directly inhibiting cancer cell proliferation.
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2021-01-01
Industry:
Cell, Gene & Biologics Therapeutics
Employee Number:
1-10
Super Industry:
Biopharma & Life Science Tools
Investors:
Innosuisse
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland